MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arcus Capital Partners, LLC | 15,000 | $19,350 | 0.01% |
| Golden State Equity Partners | 14,400 | $18,576 | 0.01% |
| Renaissance Technologies | 1,727,570 | $2,229 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 120,584 | $155,553 | 0.00% |
| Virtu Financial LLC | 34,093 | $44 | 0.00% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 20,000 | $25,800 | 0.00% |
| XTX Topco Ltd | 11,313 | $14,594 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 800,000 | $1,032,000 | 0.00% |
| Centiva Capital, LP | 25,000 | $32,250 | 0.00% |
| Citadel Advisors | 2,242,425 | $2,892,728 | 0.00% |
| Schonfeld Strategic Advisors LLC | 130,600 | $168,474 | 0.00% |
| GOLDMAN SACHS GROUP INC | 2,023,672 | $2,610,537 | 0.00% |
| OneDigital Investment Advisors LLC | 26,300 | $33,927 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,243,585 | $1,604,225 | 0.00% |
| SRS Capital Advisors, Inc. | 4,000 | $5,160 | 0.00% |
| SIT INVESTMENT ASSOCIATES INC | 970 | $1 | 0.00% |
| BARCLAYS PLC | 76 | $0 | 0.00% |
| Creative Planning | 15,820 | $20,408 | 0.00% |
| Allworth Financial LP | 1,500 | $1,935 | 0.00% |
| JPMORGAN CHASE & CO | 132,801 | $171,313 | 0.00% |
External links
This page lists MEREO BIOPHARMA GROUP PLC's shareholders in Q3 2023. To view MEREO BIOPHARMA GROUP PLC's shareholder history, click here.